LAZARD ASSET MANAGEMENT LLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 126 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$123
-10.2%
4,350
-7.5%
0.00%
Q4 2022$137
-99.9%
4,703
+8.6%
0.00%
Q3 2022$114,000
-40.6%
4,3300.0%0.00%
Q2 2022$192,000
+62.7%
4,330
+80.1%
0.00%
Q1 2022$118,000
-3.3%
2,404
-0.0%
0.00%
Q4 2021$122,000
+1.7%
2,405
+11.5%
0.00%
Q3 2021$120,000
+62.2%
2,157
+34.0%
0.00%
Q4 2020$74,000
+1380.0%
1,610
+1208.9%
0.00%
Q3 2020$5,000
-91.8%
123
-90.4%
0.00%
Q2 2020$61,000
-99.7%
1,277
-99.6%
0.00%
-100.0%
Q2 2018$24,388,000
+42.7%
322,340
-0.6%
0.04%
+44.8%
Q1 2018$17,085,000
-13.0%
324,257
-11.8%
0.03%
-14.7%
Q4 2017$19,631,000
-6.4%
367,497
+4.5%
0.03%
-10.5%
Q3 2017$20,973,000
-4.5%
351,673
+26.4%
0.04%
-7.3%
Q2 2017$21,953,000
+990.6%
278,282
+1046.4%
0.04%
+925.0%
Q1 2017$2,013,000
-24.0%
24,275
-27.3%
0.00%
-20.0%
Q4 2016$2,649,000
+13.3%
33,4000.0%0.01%0.0%
Q3 2016$2,338,000
+80.5%
33,4000.0%0.01%
+66.7%
Q2 2016$1,295,00033,4000.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
JW Asset Management, LLC 475,755$25,068,00024.71%
Hudson Executive Capital LP 971,000$51,162,00015.09%
Park West Asset Management LLC 1,051,274$55,392,0002.47%
U S GLOBAL INVESTORS INC 19,200$1,012,0000.62%
Capital Impact Advisors, LLC 26,317$1,387,0000.57%
CLARK ESTATES INC/NY 56,278$2,965,0000.47%
IRIDIAN ASSET MANAGEMENT LLC/CT 873,131$46,005,0000.41%
ProQuest Associates IV LLC 6,777$357,0000.41%
Granite Investment Partners, LLC 114,207$6,017,0000.40%
GLOBEFLEX CAPITAL L P 30,900$1,628,0000.34%
View complete list of EAGLE PHARMACEUTICALS INC shareholders